UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

Role of alkaline phosphatase in colitis in man and rats

Gut, 2009-03, Vol.58 (3), p.379-387

2009

Volltextzugriff (PDF)

From benchtop to clinic: a translational analysis of the immune response to submicron topography and its relevance to bone healing

European cells & materials, 2021-06, Vol.41, p.756-773

2021

Volltextzugriff (PDF)

Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice

The Journal of pharmacology and experimental therapeutics, 2011-06, Vol.337 (3), p.628

2011

Volltextzugriff (PDF)

Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver

Journal of controlled release, 2018-01, Vol.269, p.258-265

2018

Volltextzugriff (PDF)

Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGFβ-receptor in the fibrotic kidney

International journal of pharmaceutics, 2017-12, Vol.534 (1-2), p.229-236

2017

Volltextzugriff (PDF)

The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor

Journal of controlled release, 2019-02, Vol.296, p.250-257

2019

Volltextzugriff (PDF)

Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers

The Journal of pharmacology and experimental therapeutics, 2008-03, Vol.324 (3), p.902

2008

Volltextzugriff (PDF)

Osteoprotegerin production and profibrotic activity in liver fibrosis are TGFβ dependent

Journal of hepatology, 2017, Vol.66 (1), p.S147-S147

2017

Volltextzugriff (PDF)

Osteoprotegerin is more than a serum marker in liver fibrosis

Journal of hepatology, 2017, Vol.66 (1), p.S147-S148

2017

Volltextzugriff (PDF)

Towards clinical use of targeted therapies for liver fibrosis: development of a sustained release formulation for therapeutic proteins

Journal of hepatology, 2017, Vol.66 (1), p.S44-S44

2017

Volltextzugriff (PDF)

Drug targeting to the diseased liver

Journal of controlled release, 2012-07, Vol.161 (2), p.188-197

2012

Volltextzugriff (PDF)

595 ALKALINE PHOSPHATASE IS A PROTECTIVE ENZYME DURING LIVER FIBROGENESIS

Journal of hepatology, 2013-04, Vol.58, p.S243-S243

2013

Volltextzugriff (PDF)

P341 NON-INVASIVE IMAGING OF KUPFFER CELL STATUS USING RADIOLABELLED MANNOSYLATED ALBUMIN

Journal of hepatology, 2014-04, Vol.60 (1), p.S180-S181

2014

Volltextzugriff (PDF)

2165 POSTER Targeting of Interferon Gamma to Stromal Fibroblasts Using a PDGF Receptor Recognizing Carrier Reduces Tumour Growth in Vivo

European journal of cancer (1990), 2011, Vol.47, p.S217-S217

2011

Volltextzugriff (PDF)

1056 DELIVERY OF THE INTERFERON-γ SIGNALING MOIETY TO THE PDGFβ-RECEPTOR ON HEPATIC STELLATE CELLS AMELIORATES ESTABLISHED LIVER FIBROSIS IN MICE

Journal of hepatology, 2011-03, Vol.54, p.S419-S419

2011

Volltextzugriff (PDF)

914 CELL-SPECIFIC TARGETING OF INTERFERON GAMMA TO HEPATIC STELLATE CELLS USING A CYCLIC PDGF-RECEPTOR RECOGNIZING PEPTIDE IMPROVES ITS THERAPEUTIC EFFICACY

Journal of hepatology, 2010, Vol.52, p.S354-S355

2010

Volltextzugriff (PDF)

374 HSC-DIRECTED RHO-KINASE INHIBITION IS AN EFFECTIVE AND SAVE APPROACH FOR TREATMENT OF PORTAL HYPERTENSION

Journal of hepatology, 2012-04, Vol.56, p.S151-S151

2012

Volltextzugriff (PDF)

1041 HSC SPECIFIC INHIBITION OF RHO-KINASE REDUCES PORTAL PRESSURE WITHOUT SYSTEMIC EFFECTS

Journal of hepatology, 2011-03, Vol.54, p.S414-S414

2011

Volltextzugriff (PDF)

Dephosphorylation of endotoxin by alkaline phosphatase in vivo

The American journal of pathology, 1997-10, Vol.151 (4), p.1163-1169

1997

Volltextzugriff (PDF)

A role for scavenger receptor B-I in selective transfer of rhodamine-PE from liposomes to cells

Biochemical and biophysical research communications, 2004-12, Vol.325 (3), p.908-914

2004

Volltextzugriff (PDF)

A novel spinal implant infection model in rabbits

Spine (Philadelphia, Pa. 1976), 2000-02, Vol.25 (4), p.406-410

2000

Volltextzugriff (PDF)

Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth

Molecular cancer therapeutics, 2012-11, Vol.11 (11), p.2419-2428

2012

Volltextzugriff (PDF)

Intravenous administration of recombinant human IL-10 suppresses the development of anti-thy 1-induced glomerulosclerosis in rats

PDA journal of pharmaceutical science and technology, 2011-03, Vol.65 (2), p.116

2011

Volltextzugriff (PDF)

A Role for Intestinal Alkaline Phosphatase in the Maintenance of Local Gut Immunity

The Journal of surgical research, 2010, Vol.158 (2), p.258-259

2010

Volltextzugriff (PDF)

239 15-deoxy-delta-12,14-Prostaglandin-J2 inhibits multidrug resistance genes and induces apoptosis in doxorubicin-resistant ovarian carcinoma cells

European journal of cancer supplements, 2010, Vol.8 (5), p.63-63

2010

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Role of alkaline phosphatase in colitis in man and rats

From benchtop to clinic: a translational analysis of the immune response to submicron topography and its relevance to bone healing

Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice

Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver

Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGFβ-receptor in the fibrotic kidney

The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor

Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers

Osteoprotegerin production and profibrotic activity in liver fibrosis are TGFβ dependent

Osteoprotegerin is more than a serum marker in liver fibrosis

Towards clinical use of targeted therapies for liver fibrosis: development of a sustained release formulation for therapeutic proteins

Drug targeting to the diseased liver

595 ALKALINE PHOSPHATASE IS A PROTECTIVE ENZYME DURING LIVER FIBROGENESIS

P341 NON-INVASIVE IMAGING OF KUPFFER CELL STATUS USING RADIOLABELLED MANNOSYLATED ALBUMIN

2165 POSTER Targeting of Interferon Gamma to Stromal Fibroblasts Using a PDGF Receptor Recognizing Carrier Reduces Tumour Growth in Vivo

1056 DELIVERY OF THE INTERFERON-γ SIGNALING MOIETY TO THE PDGFβ-RECEPTOR ON HEPATIC STELLATE CELLS AMELIORATES ESTABLISHED LIVER FIBROSIS IN MICE

914 CELL-SPECIFIC TARGETING OF INTERFERON GAMMA TO HEPATIC STELLATE CELLS USING A CYCLIC PDGF-RECEPTOR RECOGNIZING PEPTIDE IMPROVES ITS THERAPEUTIC EFFICACY

374 HSC-DIRECTED RHO-KINASE INHIBITION IS AN EFFECTIVE AND SAVE APPROACH FOR TREATMENT OF PORTAL HYPERTENSION

1041 HSC SPECIFIC INHIBITION OF RHO-KINASE REDUCES PORTAL PRESSURE WITHOUT SYSTEMIC EFFECTS

Dephosphorylation of endotoxin by alkaline phosphatase in vivo

A role for scavenger receptor B-I in selective transfer of rhodamine-PE from liposomes to cells

A novel spinal implant infection model in rabbits

Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth

Intravenous administration of recombinant human IL-10 suppresses the development of anti-thy 1-induced glomerulosclerosis in rats

A Role for Intestinal Alkaline Phosphatase in the Maintenance of Local Gut Immunity

239 15-deoxy-delta-12,14-Prostaglandin-J2 inhibits multidrug resistance genes and induces apoptosis in doxorubicin-resistant ovarian carcinoma cells

Suchergebnisse filtern